Skip to main content
. 2006 Sep;21(9):973–978. doi: 10.1111/j.1525-1497.2006.00509.x

Table 5.

Cancer Screening Test Rates by Provider Designation and Model Prediction of “My Patient”

Variable Population, N (%) Provider Designation, N (%) Model Prediction, N (%)


“My Patient” “Not My Patient” P Value* “My Patient” “Not My Patient” P Value*
Breast cancer, Mammography 2,636 (82.7%) 1,917 (85.9%) 719 (74.4%) .01 1,740 (87.9%) 896 (72.7%) <.001
Cervical cancer, Pap Smear 8,242 (82.7%) 5,231 (83.8%) 3,011 (80.7%) .77 4,356 (84.9%) 3,886 (80.2%) .20
Colorectal cancer§ 4,336 (47.6%) 3,256 (48.7%) 1,080 (44.1%) .74 2,975 (50.3%) 1,361 (41.6%) .02
*

P-values comparing actual and predicted patient loyalty designation to the provider using multiple regression modeling controlling for individual provider cluster with general estimating equation methods

Mammogram performed over the prior 2 years in eligible women aged 52 to 69 years old

Papanicolaou (Pap) smear performed over the prior 3 years in eligible women aged 18 to 65 years old

§

Colorectal cancer screening test performed in all patients aged 52 to 69 years old: colonoscopy in the prior 10 years; flexible sigmoidoscopy or double contrast barium enema in the prior 5 years; or fecal occult blood test in the prior year